Abolition of the RL neurovirulence phenotype of herpes simplex virus type 2 strain HG52 does not require deletion of the DR1 element of the 'a' sequence June Harland and S. Moira Brown* MRC Virology Unit, Institute of Virology, Church Street, Glasgow Gll 5JR, U.K. We have characterized a spontaneous variant of herpes simplex virus type 2 (HSV-2) strain HG52, 2616, which has 786 bp of both copies of R L deleted, but which retains 782bp upstream of the 5' end of immediate early gene 1 and 463 bp downstream of the 'a' sequence. Variant 2616 is avirulent following intracerebral inoculation of BALB/c mice, thus showing in vivo characteristics similar to those of variant 2604, described previously (a 1488 bp deletion incorporating the DR1 element of the 'a' sequence), but not to those of variant 2701, which has an intermediate neurovirulence phenotype. The deletions in variants 2616 and 2604 remove the conserved HSV-1 and -2 R L open reading frame entirely and extend downstream from it, whereas the deletion in variant 2701 removes only the 5' part. The data show that deletion of part of the 'a' sequence is not required for the production of the R L avirulence phenotype in HSV-2 strain HG52.
It is now well established that there is a genome region within the long repeats of herpes simplex virus types 1 and 2 (HSV-1 and -2) that is required for neurovirulence. The importance of a region at the right-hand end of the long segment was first recognized by Thompson et al. (1983) , who showed that these HSV-1 sequences restored a neurovirulent phenotype to a previously avirulent strain 17+/HG52 recombinant, RE6. The region required to restore virulence was subsequently identified as sequeiaces [0.82 to 0.832 map units (m.u.) ] spanning the L/S junction of HSV-1 (Thompson et al., 1989) .
In this laboratory we have isolated spontaneous deletion variants of both HSV-1 strain 17 + and HSV-2 strain HG52 which are avirulent in mice. In each case the deletions remove information from both copies of RL, between immediate early gene 1 (IE1) and the 'a' sequence. The HG52 variant 2604, in which sequences between 0 and 0-01 m.u., and 0.82 and 0-83 m.u. are deleted, has been shown to be avirulent in mice [LDso > 107 p.f.u./mouse compared to < 102 p.f.u./mouse for wild-type HG52 (Taha et al., 1989a) ]. Sequence analysis of 2604 revealed deletions of 1488 bp in both long repeats which extend from the DR1/Ub boundary of the 'a' sequence to 511 bp upstream of the 5' end of IE1 (Taha et al., 1989b) . Subsequently, a variant, 2701, was generated by exonuclease III digestion; this has a deletion of 840 bp from each copy of RL, incorporating the 5' portion of the sequences deleted from 2604 (MacLean et al., 1991b) , and an LDs0 value intermediate between those for HG52 and 2604 (5 x 105 p.f.u./mouse). A spontaneous HSV-I 0001-0377 © 1991 SGM variant, 1716, with a 759 bp deletion in both copies of R L (0 to 0-02 and 0.81 to 0.83m.u.) which is nonneurovirulent for mice (LDso 7 x 106 p.f.u./mouse compared to < 10 p.f.u./mouse for wild-type strain 17 virus) has also been isolated (MacLean et al., 1991 a) .
In HSV-I strain F, a gene encoding the polypeptide ICP34.5 has been mapped between the 'a' sequence and IEI (Ackermann et al., 1986; . The gene was originally predicted to exist from sequence analysis which identified the presence of a putative promoter within the 'a' sequence . More recently it has been suggested that ICP34.5 of strain F contributes to neurovirulence in mice . However, their observation, based on the published sequence of strain 17 +, that the gene encoding ICP34.5 is not conserved in 17 + is not compatible with its extremely high neurovirulence (LD5o < 10 p.f.u./ mouse). Our data suggest the presence of neurovirulence genes in both HSV-1 strain 17 and HSV-2 strain HG52, in the same region as the gene encoding ICP34.5. Recent sequence analysis indicates that in both strain 17 and HG52 there is a gene equivalent to that in HSV-1 strain F (D. J. McGeoch, personal communication).
The fact that the spontaneous deletions in variants 2604 and 1716 each remove one copy of DR1 from the 'a' sequence led to the suggestion from colleagues working on the RL neurovirulence locus that the lack of virulence in 2604 and 1716 might be due to the absence of normal 'a' sequence function, resulting in poor packaging indirectly affecting the multiplication and spread of virus. Here we report the isolation of a spontaneous HG52 R E deletion variant, 2615, which is non-neurovirulent in mice (not one of four animals inoculated with 107 p.fou, virus died), although the deletion does not disrupt the 'a' sequence. To allow the virulence of 2615 to be compared with that of other variants, the novel 2615 BamHI g junction fragment spanning the deletion was recombined into an HG52 subcloned stock (plaque 17) of known high virulence (LDso 10 p.f.u.; Taha et al., 1989c) to give 2616. The genomic background of variants 2616, 2604 and 2701 is therefore the same, as all three deletions have been recombined into the same subcloned stock of HG52.
Three-week-old BALB/c mice (Bantin and Kingman) were inoculated intracerebrally with 25 gl of a virus stock at various doses; four mice were inoculated with each dose. A sample of the inoculum was retitrated immediately post-injection to check that the correct dose had been administered. Mice were observed daily and scored for signs of ill-health using a points system covering a number of criteria, including weight, behaviour and appearance (Morton & Griffiths, 1985) . If animals were assessed to be suffering, they were destroyed humanely. On the basis of the number of mice which died before day 14, 2615 was completely avirulent, no mice dying with a dose of up to 10 7 p.f.u. However, when sequences spanning the R L deletion were rescued into the high virulence (plaque 17) subclone of HG52 to give variant 2616, all four mice died at an inoculating dose of 6 x 106 p.f.u., but none died with 106 p.f.u. The virulence of 2616 appeared to be similar to that of 2604; one animal died at an input dose of 106 p.f.u. 2604, whereas no animal died with l0 s p.f.u, and other doses were not given. However, the number of animals used was too small to draw firm conclusions. There does appear to be a genuine difference between 2616, which killed no animals (0/4) at doses of 106 p.f.u., and 2701, which killed all four mice at a dose of 106 p.f.u. The particle :p.f.u. ratios of the viruses were for HG52 605 : 1, for 2604 795 : 1 and for 2616 560 : 1, all of which are comparable and within the normal range for HG52.
Dideoxynucleotide sequencing of an 850 bp SmaI subfragment from the novel BamHI g fragment of 2615 by the method of Sanger et al. (1977 Sanger et al. ( , 1980 ) revealed a 786 bp deletion extending from 782 bp upstream of the 5' end of IE1 to 463 bp downstream from the 'a' sequence; the deletion therefore includes the complete 189 bp RL open reading frame (ORF) (Fig. 1) .
The difference in virulence between 2701 and 2616 can not immediately be explained. The 840 bp deletion in 2701 was made by exonuclease III digestion from the unique PflMI site near the middle of the RL ORF (MacLean et al., 1991b) , the endpoints of the deletion being at 12486 (the PflMI site) and 13325 (the co- ordinates are relative to the BamHI k/f site). The sequences deleted in 2616 and 2604 completely remove the conserved HSV-1 and -2 R E ORF, which encodes 63 amino acids, whereas the deletion in 2701 removes only the 5' portion of this sequence. The predicted initiation codon for this neurovirulence determining gene would be removed in both 2604 and 2701. However, the intermediate growth and neurovirulence of 2701 (MacLean et aL, 1991 b) suggest that an aberrant, semi-functional protein is made. This would require the use of an alternative initiation codon. In conclusion we have shown that 2616 is avirulent in mice, with in vivo characteristics comparable to those of 2604. It is evident, therefore, that deletion of the DR 1 element of the 'a' sequence is not responsible for the nonneurovirulent phenotype of 2604. Also, if disruption of the 'a' sequence does impair packaging, the particle :p.f.u. ratio of 2604 would be expected to be high, whereas it is very similar to that of the wild-type. These data not only delimit the region of DNA upstream of the R E ORF that must be ddeted to achieve avirulence, but also show conclusively that this does not require involvement of the 'a' sequence.
Note added in proof. Further animal experiments which doubled the number of mice tested have confirmed the data showing that 2616 and 2604 are avirulent with comparable neurovirulence values, whereas the value for 2701 is intermediate.
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